Proteasome: target for acute and chronic GVHD?

Blood. 2014 Sep 4;124(10):1551-2. doi: 10.1182/blood-2014-07-589309.

Abstract

In this issue of Blood, Pai et al provide exciting murine and clinical data for proteasome inhibition in the treatment of chronic graft-versus-host disease (cGVHD).

Publication types

  • Comment

MeSH terms

  • Animals
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Female
  • Graft vs Host Disease / drug therapy*
  • Pyrazines / therapeutic use*

Substances

  • Boronic Acids
  • Pyrazines
  • Bortezomib